DeutschNewstral
Grail Inc.
The Interplay: Key Decisions at the Intersection of Antitrust & Life Sciences - November 2023jdsupra.com- Will the FTC Evade a String of Constitutional Attacks?jdsupra.com
Illumina pushes back against activist investor Carl Icahn's bid for board seatssandiegouniontribune.com
EU Opens Probe Into Illumina’s Decision to Close Grail Deal Despite Antitrust Concernswsj.com- Illumina Completes Deal for Grail Despite FTC Antitrust Challengewsj.com
- FTC's Drop Of Illumina-Grail Merger Case Raises Uncertaintyjdsupra.com
- Illumina Battles U.S., European Antitrust Enforcers on Grail Dealwsj.com
Houston was a finalist for Grail Inc.'s $100M, 400-job oncology research projectbizjournals.com- FTC Challenges Illumina’s Proposed Acquisition of Liquid-Biopsy Firm Grailwsj.com
- MAnalysts question Illumina's plans to buy cancer-detection company Grailmarketwatch.com
- Sequencing Firm Illumina to Pay $7.1 Billion for Liquid-Biopsy Firm Grailwsj.com
- MIllumina's stock falls after WSJ report of $7.1 billion cash and stock deal to buy Grailmarketwatch.com
- MIllumina's stock falls after Bloomberg reports it is considering acquisition of Grail Inc.marketwatch.com
- MCancer detection company Grail files to go publicmarketwatch.com
- CCompanies report progress on blood tests to detect cancerchicago.suntimes.com
Companies report progress on blood tests to detect cancer - Fri, 31 May 2019 PSTThe Spokesman-Review- NExperimental blood test takes major strides in detecting early stage cancernypost.com
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.